Miclodin (Clotrimazole)

Clotrimazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of the fungal cell membrane. Without ergosterol, the membrane becomes defective, leading to fungal cell death and resolution of the infection.

The specific dose and duration of Miclodin therapy are determined by the prescribing healthcare professional based on the severity of the infection and patient factors. Patients should follow the prescriber’s instructions and the product label carefully.

Safety data for clotrimazole during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits with their healthcare provider before using Miclodin.

To request Miclodin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Clotrimazole, the active ingredient in Miclodin, is a broad‑spectrum imidazole antifungal that is generally well‑tolerated and effective for most vaginal yeast infections. Compared with polyene agents such as nystatin, clotrimazole often requires a shorter treatment course and has a lower incidence of systemic side effects.

Miclodin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposing it to direct sunlight.

Miclodin is applied intravaginally, typically using the supplied applicator or tablet form, as directed by the prescriber. The medication is inserted into the vagina for the prescribed duration, usually once daily, and patients should avoid sexual intercourse or tampon use during treatment unless advised otherwise.

Although rare, serious adverse reactions can include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, or persistent ulceration of the vaginal mucosa. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, widespread rash, or worsening pain.

Miclodin should not be used by individuals with a known hypersensitivity to clotrimazole, other imidazole antifungals, or any of the product’s excipients. It is also contraindicated in patients who are currently using other intravaginal medications that could interact, unless advised by a healthcare professional.